GENERAL ATLANTIC, L.P. Diversified Active

Location: New York, NY

CIK: 0001017645 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 14, 2026

Total Value: $2.907B (100.0% shares, 0.0% debt)

Holdings (12)

LFTO LIFTOFF MOBILE 20.9%

Value $608M Shares 25,315,646 Est. Cost — Unrealized —

DLO DLOCAL 20.9%

Value $606M Shares 46,656,695 Est. Cost — Unrealized —

CHYM CHIME 15.0%

Value $435M Shares 21,259,683 Est. Cost — Unrealized —

ALKT ALKAMI 12.1%

Value $351M Shares 19,379,038 Est. Cost — Unrealized —

XP XP, INC 11.5%

Value $334M Shares 20,566,133 Est. Cost — Unrealized —

PHVS PHARVARIS 7.8%

Value $227M Shares 6,550,757 Est. Cost — Unrealized —

SPTX SEAPORT THERAPEUTICS 4.6%

Value $133M Shares 6,101,582 Est. Cost — Unrealized —

NRIX NURIX THERAPEUTICS 2.5%

Value $73.56M Shares 3,032,185 Est. Cost — Unrealized —

RVMD REVOLUTION MEDICINES 2.3%

Value $67.01M Shares 357,791 Est. Cost — Unrealized —

PBLS PARABILIS MEDICINES 1.4%

Value $42.11M Shares 1,538,461 Est. Cost — Unrealized —

RSKD RISKIFIED 0.9%

Value $26.84M Shares 5,324,998 Est. Cost — Unrealized —

GROV GROVE COLLABORATIVE 0.1%

Value $3.094M Shares 2,474,859 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
LFTO	LIFTOFF MOBILE	25,315,646	$608M	20.9%	—	—	COM	53229X101
DLO	DLOCAL	46,656,695	$606M	20.9%	—	—	CL A	G29018101
CHYM	CHIME	21,259,683	$435M	15.0%	—	—	COM SHS CL A	16935C109
ALKT	ALKAMI	19,379,038	$351M	12.1%	—	—	COM	01644J108
XP	XP, INC	20,566,133	$334M	11.5%	—	—	CL A	G98239109
PHVS	PHARVARIS	6,550,757	$227M	7.8%	—	—	COM	N69605108
SPTX	SEAPORT THERAPEUTICS	6,101,582	$133M	4.6%	—	—	COM	81221K108
NRIX	NURIX THERAPEUTICS	3,032,185	$73.56M	2.5%	—	—	COM	67080M103
RVMD	REVOLUTION MEDICINES	357,791	$67.01M	2.3%	—	—	COM	76155X100
PBLS	PARABILIS MEDICINES	1,538,461	$42.11M	1.4%	—	—	COM	698955101
RSKD	RISKIFIED	5,324,998	$26.84M	0.9%	—	—	CL A	M8216R109
GROV	GROVE COLLABORATIVE	2,474,859	$3.094M	0.1%	—	—	CL A	39957D201